[Cardioprotective effects of natriuretic peptides].
Horio
Takeshi
T
Division of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center.
D000818:Animals; D019898:Autocrine Communication; D006332:Cardiomegaly / Q000209:etiology / Q000517:prevention & control*; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use; D003094:Collagen / Q000096:biosynthesis; D003864:Depression, Chemical; D004719:Endomyocardial Fibrosis / Q000209:etiology / Q000517:prevention & control*; D019332:Endothelin-1 / Q000096:biosynthesis; D006801:Humans; D045265:Natriuretic Peptides / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D019899:Paracrine Communication; D020257:Ventricular Remodeling
D002316:Cardiotonic Agents; D019332:Endothelin-1; D045265:Natriuretic Peptides; D003094:Collagen